beta-alanine has been researched along with Lung Diseases, Interstitial in 1 studies
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both early treatment and late treatment with dabigatran etexilate attenuated the development of bleomycin-induced pulmonary fibrosis." | 3.77 | Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease. ( Akter, T; Bogatkevich, GS; Ludwicka-Bradley, A; Nietert, PJ; Silver, RM; van Ryn, J, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bogatkevich, GS | 1 |
| Ludwicka-Bradley, A | 1 |
| Nietert, PJ | 1 |
| Akter, T | 1 |
| van Ryn, J | 1 |
| Silver, RM | 1 |
1 other study available for beta-alanine and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Antiinflammatory and antifibrotic effects of the oral direct thrombin inhibitor dabigatran etexilate in a murine model of interstitial lung disease.
Topics: Administration, Oral; Animals; Antithrombins; Benzimidazoles; beta-Alanine; Bleomycin; Dabigatran; D | 2011 |